Avalo Therapeutics (AVTX) Net Margin (QoQ) (2016 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Avalo Therapeutics | 317.29 Mn | 317.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -2.77 Mn |
| Dec 31, 2023 | 78,478.00 |
| Sep 30, 2023 | -94,107.00 |
| Jun 30, 2023 | 82,161.00 |
| Dec 31, 2021 | -3,531.00 |
| Sep 30, 2021 | 357.00 |
| Jun 30, 2021 | 2,447.00 |
| Mar 31, 2021 | -5,574.00 |
| Dec 31, 2020 | 5,116.00 |
| Sep 30, 2020 | 1,618.00 |
| Jun 30, 2020 | -7,170.00 |
| Mar 31, 2020 | -121,139.00 |
| Dec 31, 2019 | 129,841.00 |
| Sep 30, 2019 | 21,497.00 |
| Jun 30, 2019 | -17,535.00 |
| Mar 31, 2019 | -10,131.00 |
| Dec 31, 2018 | 61,616.00 |
| Sep 30, 2018 | -47,826.00 |
| Jun 30, 2018 | -3,893.00 |
| Mar 31, 2018 | 7,517.00 |
| Dec 31, 2017 | -23,655.00 |
| Sep 30, 2017 | 121,451.00 |
| Jun 30, 2017 | -62,943.00 |
| Mar 31, 2017 | 39,008.00 |
| Dec 31, 2016 | 101,836.00 |
| Sep 30, 2016 | -136,301.00 |